Advanced molecular test can improve diagnosis of a genetic form of COPD

National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test capable of accurately diagnosing a major genetic cause of chronic obstructive pulmonary disease (COPD) known as Alpha-1 Antitrypsin Deficiency (AATD).

See also  Study reveals potential effects of uterine artery embolization on subsequent deliveries
Total
0
Share
Need Help?